Premarket Mover: LAVA Therapeutics NV (LVTX) Down 4.66%

LAVA Therapeutics NV (LVTX) has fallen Monday morning, with the stock declining -4.66% in pre-market trading to 1.84. LVTX's short-term technical score of 48 indicates that the stock has traded less bullishly over the last month than 52% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, LVTX ranks higher than 67% of stocks. LAVA Therapeutics NV has fallen 23.11% over the past month, closing at $2.27 on June 12. During this period of time, the stock fell as low as $1.91 and as high as $2.52. LVTX has an average analyst recommendation of Strong Buy. The company has an average price target of $9.80.

LVTX has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on LVTX!

See Full LVTX Report

LAVA Therapeutics NV has a Long-Term Technical rank of 19. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 81% of the market scoring higher. In the Biotechnology industry which is number 119 by this metric, LVTX ranks better than 119% of stocks.

Important Dates for Investors in LVTX:

-LAVA Therapeutics NV is set to release earnings on 9/6/2023. Over the last 12 months, the company has reported EPS of $-1.23. -We do not have a set dividend date for LAVA Therapeutics NV at this time. Click Here To Get The Full Report on LAVA Therapeutics NV (LVTX)